Bioventix PLC, a biotechnology company, manufactures and supplies sheep monoclonal antibodies (SMAs) for use in diagnostics applications. The company offers a portfolio of purified SMAs for the clinical diagnostics market for thyroid, vitamin D, cardiovascular, drugs of abuse, fertility testing, infectious disease, oncology, and miscellaneous. It also provides contract SMAs and recombinant services. The company was founded in 2003 and is based in Farnham, the United Kingdom.